Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MIR4697HG
   Synonyms MIR4697HG, LINC00947, LINC00947, LOC283174
   Region GRCh38_11:133896438-133901601    Sequence
   Ensembl ENSG00000280237
   RefSeq NR_024344
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name ovarian cancer
   ICD-0-3 C56.9  
   Methods qPCR, RNAi, Western blot, Cell migration and invasion assay etc.
   Sample ovarian cancer tissues, cell lines (CoC1, CaoV-3, OVCAR3, and SKOV3)
   Expression Pattern up-regulated
   Function Description

The transcriptional level of MIR4697HG was increased in cancerous tissues and ovarian cancer cell lines.MIR4697HG knockdown by specific shRNA significantly inhibited cell proliferation and colony formation in both OVCAR3 and SKOC3 cells. Furthermore, MIR4697HG knockdown inhibited cell migration and invasion capacities. MIR4697HG knockdown also caused a decrease in matrix metalloprotease-9, phosphorylated ERK, and phosphorylated AKT.

   Pubmed ID 28168162
   Year 2017
   Title Long Noncoding RNA MIR4697HG Promotes Cell Growth and Metastasis in Human Ovarian Cancer.
   External Links
   Links for  MIR4697HG GenBank       HGNC       lncrnadb       Noncode
   Links for  ovarian cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.